Michael A. Pratta

3.7k total citations
42 papers, 2.1k citations indexed

About

Michael A. Pratta is a scholar working on Rheumatology, Cancer Research and Oncology. According to data from OpenAlex, Michael A. Pratta has authored 42 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Rheumatology, 17 papers in Cancer Research and 12 papers in Oncology. Recurrent topics in Michael A. Pratta's work include Osteoarthritis Treatment and Mechanisms (17 papers), Protease and Inhibitor Mechanisms (13 papers) and Cell Adhesion Molecules Research (10 papers). Michael A. Pratta is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (17 papers), Protease and Inhibitor Mechanisms (13 papers) and Cell Adhesion Molecules Research (10 papers). Michael A. Pratta collaborates with scholars based in United States, Sweden and Germany. Michael A. Pratta's co-authors include Elizabeth C. Arner, Micky D. Tortorella, Rui‐Qin Liu, James M. Trzăskos, Sanjay Kumar, Carl P. Decicco, Ilgar Abbaszade, Timothy C. Burn, Robert Newton and Michael W. Lark and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Michael A. Pratta

41 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael A. Pratta United States 21 1.1k 690 527 493 397 42 2.1k
Ngee Han Lim United Kingdom 19 496 0.5× 506 0.7× 223 0.4× 424 0.9× 86 0.2× 30 1.4k
Simon Blake United States 19 803 0.8× 215 0.3× 147 0.3× 574 1.2× 89 0.2× 25 1.6k
Hans‐Georg Wisniewski United States 22 263 0.2× 165 0.2× 332 0.6× 724 1.5× 623 1.6× 33 1.8k
Shuling Ren China 28 296 0.3× 585 0.8× 338 0.6× 1.3k 2.7× 137 0.3× 46 2.5k
Elena V. Tchetina Russia 16 924 0.9× 243 0.4× 173 0.3× 463 0.9× 93 0.2× 37 1.3k
Sylvia M. Wilson Canada 27 851 0.8× 643 0.9× 181 0.3× 1.3k 2.7× 251 0.6× 44 2.7k
Tetsuro Ikebe Japan 28 257 0.2× 680 1.0× 160 0.3× 1.2k 2.5× 166 0.4× 81 2.5k
Ulrike Benbow United States 18 176 0.2× 1.0k 1.5× 342 0.6× 839 1.7× 115 0.3× 25 1.9k
Ya Zhuo United States 21 657 0.6× 204 0.3× 101 0.2× 1.4k 2.8× 189 0.5× 41 2.2k
Manuel A. Pallero United States 23 139 0.1× 240 0.3× 317 0.6× 920 1.9× 526 1.3× 28 1.7k

Countries citing papers authored by Michael A. Pratta

Since Specialization
Citations

This map shows the geographic impact of Michael A. Pratta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Pratta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Pratta more than expected).

Fields of papers citing papers by Michael A. Pratta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Pratta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Pratta. The network helps show where Michael A. Pratta may publish in the future.

Co-authorship network of co-authors of Michael A. Pratta

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Pratta. A scholar is included among the top collaborators of Michael A. Pratta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Pratta. Michael A. Pratta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Frigault, Matthew J., Richard T. Maziarz, Jae H. Park, et al.. (2025). Itacitinib for the prevention of IEC therapy–associated CRS: results from the 2-part phase 2 INCB 39110-211 study. Blood. 146(4). 422–436. 1 indexed citations
2.
Schroeder, Mark A., H. Jean Khoury, Madan Jagasia, et al.. (2020). A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease. Blood Advances. 4(8). 1656–1669. 72 indexed citations
3.
Hoffman, Bryan E., Shen Wang, Charles R. Hanning, et al.. (2009). Development and characterization of a human articular cartilage‐derived chondrocyte cell line that retains chondrocyte phenotype. Journal of Cellular Physiology. 222(3). 695–702. 16 indexed citations
4.
Chaturvedi, Pankaj, et al.. (2006). Functional characterization of an orphan nuclear receptor, Rev‐ErbAα, in chondrocytes and its potential role in osteoarthritis. Arthritis & Rheumatism. 54(11). 3513–3522. 14 indexed citations
5.
Kirkpatrick, Robert B., Michael Grooms, Feilan Wang, et al.. (2006). Bacterial production of biologically active canine interleukin-1β by seamless SUMO tagging and removal. Protein Expression and Purification. 50(1). 102–110. 10 indexed citations
6.
DiMicco, Michael A., Parth Patwari, Patrick N. Siparsky, et al.. (2004). Mechanisms and kinetics of glycosaminoglycan release following in vitro cartilage injury. Arthritis & Rheumatism. 50(3). 840–848. 83 indexed citations
7.
Liu, Rui‐Qin, et al.. (2003). A microplate assay specific for the enzyme aggrecanase. Analytical Biochemistry. 314(2). 260–265. 23 indexed citations
8.
Tortorella, Micky D., Michael A. Pratta, Rui‐Qin Liu, et al.. (2000). Sites of Aggrecan Cleavage by Recombinant Human Aggrecanase-1 (ADAMTS-4). Journal of Biological Chemistry. 275(24). 18566–18573. 192 indexed citations
9.
Tortorella, Micky D., Michael A. Pratta, Rui‐Qin Liu, et al.. (2000). The Thrombospondin Motif of Aggrecanase-1 (ADAMTS-4) Is Critical for Aggrecan Substrate Recognition and Cleavage. Journal of Biological Chemistry. 275(33). 25791–25797. 162 indexed citations
10.
Mercuri, Francesca, Kurt Doege, Elizabeth C. Arner, et al.. (1999). Recombinant Human Aggrecan G1-G2 Exhibits Native Binding Properties and Substrate Specificity for Matrix Metalloproteinases and Aggrecanase. Journal of Biological Chemistry. 274(45). 32387–32395. 37 indexed citations
11.
Pratta, Michael A., Neil R. Ackerman, & Elizabeth C. Arner. (1998). Effect of ebselen on IL-1-induced alterations in cartilage metabolism. Inflammation Research. 47(3). 115–121. 10 indexed citations
12.
Scherle, Peggy, et al.. (1997). The Effects of IL-1 on Mitogen-Activated Protein Kinases in Rabbit Articular Chondrocytes. Biochemical and Biophysical Research Communications. 230(3). 573–577. 46 indexed citations
13.
Pratta, Michael A.. (1995). Biological evaluation of matrix metalloproteinase inhibitors, 18 May 1995, New York. Inflammation Research. 44(11). 458–460. 3 indexed citations
14.
Rosenfeld, Stuart A., et al.. (1994). Production of human matrix metalloproteinase 3 (stromelysin) in Escherichia coli. Gene. 139(2). 281–286. 14 indexed citations
15.
Lyons-Giordano, Bernadette, Michael A. Pratta, W Galbraith, Gary L. Davis, & Elizabeth C. Arner. (1993). Interleukin-1 Differentially Modulates Chondrocyte Expression of Cyclooxygenase-2 and Phospholipase A2. Experimental Cell Research. 206(1). 58–62. 97 indexed citations
16.
Ogata, Yutaka, Michael A. Pratta, Hideaki Nagase, & Elizabeth C. Arner. (1992). Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) is induced in rabbit articular chondrocytes by cotreatment with interleukin 1β and a protein kinase C activator. Experimental Cell Research. 201(2). 245–249. 55 indexed citations
17.
Arner, Elizabeth C. & Michael A. Pratta. (1989). Independent effects of interleukin‐1 on proteoglycan breakdown, proteoglycan synthesis, and prostaglandin E2 release from cartilage in organ culture. Arthritis & Rheumatism. 32(3). 288–297. 108 indexed citations
18.
Pratta, Michael A., et al.. (1989). Effect of interleukin-1-β and tumor necrosis factor-α on cartilage proteoglycan metabolismin vitro. Inflammation Research. 27(3-4). 250–253. 34 indexed citations
19.
Arner, Elizabeth C., et al.. (1989). In vivo studies on the effects of human recombinant interleukin-1β on articular cartilage. Inflammation Research. 27(3-4). 254–257. 18 indexed citations
20.
Arner, Elizabeth C., et al.. (1987). Effect of antiinflammatory drugs on human interleukin-1-induced cartilage degradation. Inflammation Research. 21(3-4). 334–336. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ngee Han Lim Breakdown of academic impact, for papers by Simon Blake Breakdown of academic impact, for papers by Hans‐Georg Wisniewski Breakdown of academic impact, for papers by Shuling Ren Breakdown of academic impact, for papers by Elena V. Tchetina Breakdown of academic impact, for papers by Sylvia M. Wilson Breakdown of academic impact, for papers by Tetsuro Ikebe Breakdown of academic impact, for papers by Ulrike Benbow Breakdown of academic impact, for papers by Ya Zhuo Breakdown of academic impact, for papers by Manuel A. Pallero
Rankless by CCL
2026